Document Detail


Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by (1) H-magnetic resonance spectroscopy in a rat model.
MedLine Citation:
PMID:  21261727     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Background and Aim:  Living donors with marked (> 33%) macrovesicular steatosis (MaS) are excluded from living donor liver transplantation procedures. Experimental studies have shown that the development of steatosis can be prevented by supplementation with omega-3 fatty acids (FA), but no studies have investigated the reduction of steatosis using omega-3 FA. The aim of the present study was to investigate whether administration of omega-3 FA is effective in reducing steatosis. Methods:  After fatty liver (FL) induction by a 3-week methionine/choline-deficient (MCD) diet, male Wistar rats were daily administered per gavage omega-3 FA (FL+Omega-3), omega-3-poor lipid solution (FL+Lipid), or NaCl (FL+NaCl) during 2 weeks. Control animals received standard chow without treatment. Determination of steatosis degree was performed before, during, and after treatment by clinical 3.0T (1) H-magnetic resonance spectroscopy ((1) H-MRS) and by histology and gas chromatography at the end of the 2-week treatment period. Results:  Hepatic fat content ((1) H-MRS) was significantly reduced after 1 and 2 weeks of omega-3 FA treatment. Histological analysis revealed a mild (5-33%) MaS degree in omega-3-treated animals vs severe (> 66%) MaS in the FL+Lipid and FL+NaCl groups. Hepatic omega-6 : 3 FA ratio and total FA content were reduced in the FL+Omega-3 group. Furthermore, de novo lipogenesis (C16, C16 : 1ω7, C18 : 1ω9) was also lowered. The reduction in hepatic fat content was associated with decreased lobular inflammation and hepatic tumor necrosis factor- α and interleukin levels as well as an increased antioxidative capacity. Conclusion:  Omega-3 FA are capable of reversing severe hepatic MaS and ameliorating pathophysiological features of non-alcoholic steatohepatitis such as hepatocellular damage, lobular inflammation, and a reduced antioxidative capacity.
Authors:
Hendrik A Marsman; Michal Heger; Jaap J Kloek; Syert L Nienhuis; Jochem R van Werven; Aart J Nederveen; Fiebo Jw Ten Kate; Jaap Stoker; Thomas M van Gulik
Related Documents :
12741857 - Body composition in division i football players.
18818077 - The relationship between regional body composition and quantitative strength in faciosc...
11404217 - Magnitude and variation of ratio of total body potassium to fat-free mass: a cellular l...
2080787 - Volume status and body composition of chronic dialysis patients: utility of bioelectric...
21928167 - Zym-201 sodium succinate ameliorates streptozotocin-induced hyperlipidemic conditions.
9250517 - Effect of dietary vitamin e supplementation on the integrity of skeletal muscle in exer...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of gastroenterology and hepatology     Volume:  26     ISSN:  1440-1746     ISO Abbreviation:  J. Gastroenterol. Hepatol.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8607909     Medline TA:  J Gastroenterol Hepatol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  356-63     Citation Subset:  IM    
Copyright Information:
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
Affiliation:
Department of Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands, Department of Radiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands and Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Platelets prevent acute hepatitis induced by anti-fas antibody.
Next Document:  Expression and modulation of Na(+) /H(+) exchanger 1 gene in hepatocellular carcinoma: A potential t...